Junaid Husain is the Medical Technology Analyst for Soleil Securities. He is a 15-year veteran of the health care industry. Previously, Mr. Husain was with Leerink Swann & Co., where he was Vice President/Research Analyst on the medical supplies and diagnostics team. Prior to Leerink Swann, he was a Management Consultant for Constella Health Strategies and Decision Resources, providing advisory services to pharmaceutical and biotechnology companies. Mr. Husain is an entrepreneur, having worked for startup companies in the genomics, biochemical manufacturing and medical device industries. Mr. Husain's academic credentials include an undergraduate degree in anatomy from the University of Saskatchewan, a master's degree in neuroscience from McGill University, an MBA from Queen's University and a master's degree in government from Harvard University. Profile
TWST: I was wondering how your coverage universe has changed, if at all, since the last time you spoke with us in January?
Mr. Husain: No, it hasn't. The coverage universe is still the same. I cover